NO955313L - Anvendelse av ropivacain i fremstillingen av et farmasöytikum med analgetisk effekt som har minimal motorisk blokkering - Google Patents

Anvendelse av ropivacain i fremstillingen av et farmasöytikum med analgetisk effekt som har minimal motorisk blokkering

Info

Publication number
NO955313L
NO955313L NO955313A NO955313A NO955313L NO 955313 L NO955313 L NO 955313L NO 955313 A NO955313 A NO 955313A NO 955313 A NO955313 A NO 955313A NO 955313 L NO955313 L NO 955313L
Authority
NO
Norway
Prior art keywords
ropivacaine
preparation
pharmaceutical
analgesic effect
minimal motor
Prior art date
Application number
NO955313A
Other languages
English (en)
Other versions
NO955313D0 (no
Inventor
Arne Torsten Eek
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO955313(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO955313D0 publication Critical patent/NO955313D0/no
Publication of NO955313L publication Critical patent/NO955313L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Electromechanical Clocks (AREA)
  • Particle Accelerators (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Air Conditioning Control Device (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Anvendelse av et farmasøytisk akseptabelt salt av ropivacain for fremstilling av et farmasøytisk preparat med sensorisk blokkering og minimal motorisk blokade.
NO955313A 1993-06-28 1995-12-27 Anvendelse av ropivacain i fremstillingen av et farmasöytikum med analgetisk effekt som har minimal motorisk blokkering NO955313L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use
PCT/SE1994/000496 WO1995000148A1 (en) 1993-06-28 1994-05-26 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade

Publications (2)

Publication Number Publication Date
NO955313D0 NO955313D0 (no) 1995-12-27
NO955313L true NO955313L (no) 1995-12-27

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955313A NO955313L (no) 1993-06-28 1995-12-27 Anvendelse av ropivacain i fremstillingen av et farmasöytikum med analgetisk effekt som har minimal motorisk blokkering

Country Status (32)

Country Link
US (2) US5670524A (no)
EP (1) EP0706395B1 (no)
JP (1) JP3725541B2 (no)
CN (1) CN1074918C (no)
AT (1) ATE216237T1 (no)
BR (1) BR9406865A (no)
CA (1) CA2165446C (no)
CZ (1) CZ283300B6 (no)
DE (2) DE706395T1 (no)
DK (1) DK0706395T3 (no)
EE (1) EE03205B1 (no)
ES (1) ES2099048T3 (no)
FI (1) FI956269L (no)
GR (1) GR970300013T1 (no)
HU (1) HU218949B (no)
IL (1) IL110006A (no)
IS (1) IS4174A (no)
LT (1) LT3449B (no)
LV (1) LV12918B (no)
MY (1) MY119360A (no)
NO (1) NO955313L (no)
NZ (1) NZ268110A (no)
PH (1) PH31258A (no)
PL (1) PL175518B1 (no)
PT (1) PT706395E (no)
RU (1) RU2152215C1 (no)
SA (1) SA94150010B1 (no)
SE (1) SE9302218D0 (no)
SG (1) SG49078A1 (no)
SK (1) SK280111B6 (no)
TW (1) TW285640B (no)
WO (1) WO1995000148A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
WO1999004771A2 (en) * 1997-07-21 1999-02-04 Darwin Discovery Limited Use of levobupivacaine
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
EP2846773A4 (en) 2012-05-10 2015-12-30 Painreform Ltd DEPOT FORMULATIONS OF A LOCAL ANESTHETICS AND METHOD FOR THE MANUFACTURE THEREOF
CN105612155A (zh) * 2012-05-10 2016-05-25 塞利克斯比奥私人有限公司 治疗局部疼痛的组合物和方法
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
JP6114841B2 (ja) 2013-02-28 2017-04-12 ダーミラ， インク．Ｄｅｒｍｉｒａ， Ｉｎｃ． グリコピロレート塩
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3379266D1 (en) * 1983-08-01 1989-04-06 Astra Laekemedel Ab L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
PH31258A (en) 1998-06-18
ATE216237T1 (de) 2002-05-15
EP0706395A1 (en) 1996-04-17
WO1995000148A1 (en) 1995-01-05
JP3725541B2 (ja) 2005-12-14
FI956269A7 (fi) 1995-12-27
PL175518B1 (pl) 1999-01-29
BR9406865A (pt) 1996-03-26
US5834489A (en) 1998-11-10
AU692161B2 (en) 1998-06-04
SA94150010B1 (ar) 2006-04-04
LV12918B (en) 2003-03-20
HU9503692D0 (en) 1996-02-28
SK164695A3 (en) 1996-07-03
SE9302218D0 (sv) 1993-06-28
NO955313D0 (no) 1995-12-27
LTIP1958A (en) 1995-01-31
IL110006A0 (en) 1994-11-11
DE706395T1 (de) 1997-09-04
HU218949B (hu) 2001-01-29
DE69430427D1 (de) 2002-05-23
IL110006A (en) 1999-01-26
NZ268110A (en) 1999-06-29
GR970300013T1 (en) 1997-05-31
JPH09500620A (ja) 1997-01-21
CZ336495A3 (en) 1996-06-12
FI956269A0 (fi) 1995-12-27
DE69430427T2 (de) 2002-11-14
PT706395E (pt) 2002-09-30
EE03205B1 (et) 1999-08-16
PL312198A1 (en) 1996-04-01
CZ283300B6 (cs) 1998-02-18
SG49078A1 (en) 1998-05-18
CA2165446C (en) 2005-07-05
DK0706395T3 (da) 2002-07-22
CA2165446A1 (en) 1995-01-05
AU7086694A (en) 1995-01-17
MY119360A (en) 2005-05-31
LT3449B (en) 1995-10-25
CN1126435A (zh) 1996-07-10
ES2099048T3 (es) 2002-11-16
RU2152215C1 (ru) 2000-07-10
US5670524A (en) 1997-09-23
TW285640B (no) 1996-09-11
ES2099048T1 (es) 1997-05-16
CN1074918C (zh) 2001-11-21
SK280111B6 (sk) 1999-08-06
HUT75115A (en) 1997-04-28
HK1010344A1 (en) 1999-06-17
FI956269L (fi) 1995-12-27
IS4174A (is) 1994-12-29
EP0706395B1 (en) 2002-04-17

Similar Documents

Publication Publication Date Title
NO20053105D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag.
NO308854B1 (no) Terapeutiske forbindelser, farmasøytisk akseptable salter og formuleringer inneholdende forbindelsene, samt anvendelser derav
FI955782L (fi) Menetelmä kivun käsittelemiseksi 24-tunnin suun kautta annettavia opioidiformulointeja, joilla saadaan lääkkeen plasmatason nopea alkunousu
BR9607862A (pt) Composição farmacêutica filmogênica para administração transdérmica
NO20013566L (no) Farmasoytisk preparat med regulert frigjoringsvirkning
ITMI911299A0 (it) Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
BR0012901A (pt) Medicamentos de ß - carbolina
NO955313L (no) Anvendelse av ropivacain i fremstillingen av et farmasöytikum med analgetisk effekt som har minimal motorisk blokkering
NO304113B1 (no) Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
EE04493B1 (et) Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks
NO942343L (no) Farmasöytisk preparat med analgetisk aktivitet
FI955260A7 (fi) Transdermaalisia terapeuttisia systeemejä serotoniiniagonistien antami sta varten
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
ITMI911470A0 (it) N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
DK1052991T3 (da) Topisk anvendelse af loperamid til behandling af mikrobielle infektioner
FI953725A0 (fi) Ornitiiniaminotransferaasi-inhibiittorien käyttö lääkeaineen valmistamiseksi Alzheimerin taudin hoitamiseksi
SK66U (sk) Analgetický prostriedok s protizápalovým, antiseptickým a hojivým účinkom
SE9300725D0 (sv) New use of composition for administration of drugs and method for administration of drugs
NO920031D0 (no) Synergistisk middel for terapeutisk behandling, preparat inneholdende nevnte middel, og anvendelse av middelet for fremstilling av et legemiddelpreparat
ITMI921181A1 (it) 2-(sostituite immino)-tiazolidine e procedimento per la loro preparazione e loro impiego quali antianginose e/o analgesiche
NO990948D0 (no) Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av HTLV-1-infeksjoner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application